Greg Troiano, MSE, Vice President of Technology and Chief Engineer, Seer, Inc.

Biomolecular Biosensors for Health Monitoring and Disease Detection - An Update

Ulrich von Andrian, M.D., Ph.D. Mallinckrodt Professor of Immunopathology, Harvard Medical School

Using Nanomaterials to Communicate with the Immune System

Zohreh Amoozgar, PhD, Post Doctoral Research Fellow, Harvard Medical School at Massachusetts General Hospital

Reprogramming the Tumor Microenvironment to Improve Immunotherapy

Gilles Besin, PhD, Sr. Director, Immunology, Moderna Therapeutics

Accelerated Blood Clearance of Lipid Nanoparticles Entails a Biphasic Humoral Response of B-1 Followed by B-2 Lymphocyte to Distinct Antigenic Moieties

Zhaohua Richard Huang, PhD, Senior Director of Research and Development, L.E.A.F. Pharmaceuticals

Case Studies on CMC and Regulatory Challenges of Liposomal Drug Development

Hakho Lee, Ph.D., Associate Professor, Harvard Medical School 

Promise of Liquid Biopsy for Cancer Management

Christopher Locher, Ph.D., CEO and Founder, Versatope Therapeutics 

Membrane Vesicles for Vaccine and Therapeutic Delivery

Shiladitya Sengupta, Ph.D., Associate Professor of Medicine, Harvard Medical School and Assistant Professor of Health Sciences and Technology, MIT

Understanding Cancer Immune Interactions at the Nanoscale: Going beyond T cell immune checkpoints

Young-Ho Song, Pfizer 

 A Novel in situ Hydrophobic Ion Paring (HIP) Formulation Strategy for Clinical Product Selection of a Nanoparticle Drug Delivery System

Gokul Swaminathan, PhD, Associate Principal Scientist, Merck Exploratory Science Center, Merck Research Laboratories

Novel Immuno-Modulatory Lipid Nanoparticle Formulations for Vaccines and Immuno-Oncology Applications

Shraddha Thakkar, PhD, Principal Investigator, U.S. FDA

Title TBA